A carregar...
High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
Conjugation of small molecule agonists of Toll-like receptor 7 (TLR7) to proteins, lipids, or polymers is known to modulate potency, and the physical form or formulation of these conjugates is likely to have a major effect on their immunostimulatory activity. Here, we studied the effect of formulati...
Na minha lista:
| Publicado no: | Eur J Pharm Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Science B.V
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6137072/ https://ncbi.nlm.nih.gov/pubmed/30048801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejps.2018.07.048 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|